Milk thistle drug blocks lung cancer in mice
NEW YORK (Reuters Health) - Silibinin, a drug derived from milk thistle, destroys lung cancer in mice, investigators at the University of Colorado, Denver report in the Journal of the National Cancer Institute.
Lead investigator Dr. Rana P. Singh told Reuters Health, "We have been studying milk thistle components, silymarin and silibinin, to examine their efficacy and mechanisms against different...cancers for over a decade.
· Read The Full Lung Cancer Article From Reuters -->
·
Read All Lung Cancer News Stories -->